Press Release Archive

2022 2021  2020  2019  2018   2017
2016  2015
2014   2013
2012   2011 2010   2009
2008   2007


Stuttgart/New York – An infection with SARS-CoV-2 does not only cause severe pneumonia. Experience over recent weeks has shown that thromboses and embolisms are relatively common with COVID-19. During the body’s systemic inflammatory response, the virus seems to also attack the endothelial cells lining the interior surface of blood vessel, which results in uncontrolled blood clotting. According to an article in the medical journal TH Open (Thieme, New York, 2020), Swiss clinicians recommend the use imaging techniques to systematically screen patients for possible thromboses and aggressive treatment with agents that can dissolve these. Additional compression therapy could also be helpful.

Stuttgart/New York – Severe infections with the novel coronavirus SARS-CoV-2 activates the blood coagulation mechanism and increases the risk of life-threatening complications such as heart attack or stroke. In a review article published in Thrombosis and Haemostasis (Thieme, New York, 2020), one expert attributes these complications to the strong inflammatory response triggered by the pneumonia.

Stuttgart – In a "Letter to the Editor" published recently in the medical journal "Thrombosis and Haemostasis" (Thieme, New York, 2020), clinical pathologists point out that COVID-19 has an effect on the blood coagulation of patients. Surveys indicate that the D-dimer value of infected patients is increased, partly even to threatening levels in line with the severity of the medical condition. For this reason, the authors recommend additional examinations to investigate whether patients suffering severely from the disease may profit from accompanying treatment with anticoagulant medication.

Stuttgart, February 2020The number of cases of infection with the novel coronavirus 2019-nCoV continues to increase. The World Health Organization (WHO) has declared the new coronavirus outbreak a Public Health Emergency of International Concern on January 30, 2020. Therefore, the Thieme Group starts to provide free access to specialist information on the coronavirus and other respiratory viruses at As an international provider of medical information and services Thieme aims to support physicians worldwide in the fight against the further spread of the virus.


Sign up and be the first to get exclusive offers, sales, events, and more!

Yes, I would like to receive email newsletters with the latest news and information on products and services from Thieme Medical Publishers, Inc and selected cooperation partners in medicine and science regularly (about once a week). I agree to the use and processing of my personal information for this purpose. I can opt out at any time by clicking the "unsubscribe" link at the end of each newsletter.

Further information about data processing and your corresponding rights.

*Required field; all other fields are voluntary. We only use this information to personally address you in your newsletter.